The American Heart Association Hispanic Serving Institutions Scholars program supports priority diversification in the pipeline of healthcare professionals with the support of the Quest Diagnostics
DALLAS, August 5, 2022 /3BL Media/ - The American Heart Association, the world’s leading nonprofit organization focused on longer, healthier lives for all, is committed to addressing the lack of diversity and Hispanic inclusion in healthcare careers. As such, the AHA has announced that 30 students from across the United States and Puerto Rico have been selected to participate in the 2022-2023 Hispanic Serving Institution Scholars Program that begins in September.
Serve the World Charities, Inc. (STW), which recently received a grant from Quest Diagnostics Incorporated, hosted its first annual “Friendraiser” event. STW held the event to raise awareness and funding to support their mission to empower families in South Kansas City to find affordable, dignified, and permanent housing, while helping to distribute food and providing safe and fun community events for all.
The Board of Directors has aligned its activities to oversee the organization from an ESG perspective. Different committees of the Board and, in some cases the full Board itself, oversee various areas. Each committee’s responsibilities are included in its charter, and the full Board’s ESG responsibilities are set forth in the company’s Corporate Governance Guidelines. For example, the Governance Committee oversees the organization’s overall ESG priorities, goals, and strategies and also reviews policies, programs, and reports pertaining to environmental sustainability matters.
James E. Davis is the Chief Executive Officer (CEO)-elect and Executive Vice President, General Diagnostics, for Quest Diagnostics. As Executive Vice President, General Diagnostics, Jim managed all diagnostic testing services and the company’s operations, including sales and marketing, patient and customer services, laboratories, logistics, and billing. He has also provided enterprise oversight for Quest’s COVID-19 response, including rapid expansion of testing capacity and testing innovation.
SECAUCUS, N.J., August 8, 2022 /3BL Media/ - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2022 Disability Equality Index® (DEI) Best Places to Work for Disability Inclusion by Disability: IN and the American Association of People with Disabilities (AAPD).
Testing available at no out-of-pocket cost for qualified insured individuals at Rite Aid drive-thru locations with appointment; at all other Rite Aid locations customers can schedule to pick up at-home specimen collection kits for PCR testing
PHILADELPHIA & SECAUCUS, N.J., August 16, 2022 /3BL Media/ - Rite Aid (NYSE: RAD) announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and prevent the spread of COVID-19.
“PCR and other molecular diagnostic tests are the gold-standard for reliable COVID-19 testing. Our relationship with Rite Aid will extend our delivery of COVID-19 testing to more communities in the United States.”
I am pleased to share our 2021 Corporate Responsibility report.
In 2021, we introduced new diagnostic initiatives, innovative partnerships, and research efforts, remaining passionately committed to our company’s vision of “Empowering better health with diagnostic insights.” Our dedicated team members were able to do this despite working around the clock for a second year to meet demand for COVID-19 testing, bringing the total to 63 million tests.